Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Fig 1.

Study flowchart.

Patient selection/categorization and data collection/analysis processes are shown. Abbreviations: ARNI, angiotensin receptor-neprilysin inhibitor; BP, blood pressure; HFrEF, heart failure with reduced ejection fraction; SBP, systolic blood pressure; SNUBH, Seoul National University Bundang Hospital; SNUH, Seoul National University Hospital.

More »

Fig 1 Expand

Table 1.

Baseline characteristics.

More »

Table 1 Expand

Table 2.

Factors associated with low-dose ARNI.

More »

Table 2 Expand

Fig 2.

Time-trajectories of the ARNI dose and SBP. The 1-year trajectories of the ARNI dose and SBP (from the initiation of ARNI treatment) are plotted. Solid lines represent trend lines of SBP; dotted lines represent the trend lines of ARNI dose. Shaded areas represent the confidence interval. Abbreviations: ARNI, angiotensin receptor-neprilysin inhibitor; BP, blood pressure; SBP, systolic blood pressure.

More »

Fig 2 Expand

Fig 3.

Comparisons in one-year interval changes in echocardiographic features.

1-year interval changes in echocardiographic features were plotted, stratified by BP profiles. The error bars indicate interquartile ranges. Abbreviations: BP, blood pressure; E/e’, ratio of E to e’ velocity; LVEDVi, indexed left ventricular end-diastolic volume; LVEF, left ventricular ejection fraction; LVESVi, indexed left ventricular end-systolic volume; LVMI, left ventricular mass index.

More »

Fig 3 Expand

Table 3.

Independent predictors for mortality.

More »

Table 3 Expand

Fig 4.

Comparison of clinical outcomes between dose groups according to BP profile.

Cumulative risk curves are plotted for the low-, and intermediate- to high-dose groups, among the total population, those with a high-BP profile, and those with a low-BP profile. Abbreviations: ARNI, angiotensin receptor-neprilysin inhibitor; BP, blood pressure; HF, heart failure.

More »

Fig 4 Expand

Fig 5.

Outcome risk associated with low-dose ARNI treatment according to BP profile.

The risk of clinical outcomes associated with low-dose group was plotted, among the total population and in subgroups stratified by BP profile. Abbreviations: ARNI, angiotensin receptor-neprilysin inhibitor; BP, blood pressure; CI, confidence interval; CV, cardiovascular; HF, heart failure; HR, hazard ratio.

More »

Fig 5 Expand